TetrabenazineThird Party Manufacturing in India

Tetrabenazine works by reversibly inhibiting the vesicular monoamine transporter 2 (VMAT2) found predominantly in the central nervous system. It inhibits this transporter to help the body block the translocation of monoamines such as dopamine, serotonin, and norepinephrine from the cellular cytoplasm into synaptic vesicles, leading to their metabolic degradation. Unlike classical neuroleptics, it acts primarily as a presynaptic depletor of dopamine rather than a direct postsynaptic receptor antagonist, greatly reducing the risks of permanent tardive dyskinesia. It is highly effective and well-tolerated for hyperkinetic movement disorders.

Therapeutic Uses

• Huntington's Chorea: Suppresses severe, involuntary choreiform movements associated with progressive Huntington's disease.
• Tardive Dyskinesia: Manages persistent, drug-induced involuntary movements resulting from long-term neuroleptic usage.
• Tourette Syndrome: Functions as a specialized intervention to reduce severe motor and vocal tics when standard options fail.

Why Manufacturers Choose Tetrabenazine

Tetrabenazine third party manufacturing in India represents an essential, niche pharmaceutical category serving specialized psychiatric and neurological distribution networks. Due to the high potency and specific neurological nature of the compound, strict containment protocols and extreme accuracy in low-milligram blending are mandatory. Our partner manufacturing lines feature advanced containment systems and operate under strict WHO-GMP metrics, guaranteeing ultimate chemical purity and exact dosing integrity.